By Megan Leonhardt ( March 6, 2012, 12:49 PM EST) -- Avanir Pharmaceuticals Inc. sued drugmaker Watson Pharmaceuticals Inc. in Delaware on Friday in an effort to block plans to market a generic version of so-called involuntary emotion drug Nuedexta, the latest in a campaign of patent suits over the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.